Skip to content

Spirituality Psychotherapy (SIPT), Cognitive-behavioral Therapy (CBT) and Medication Intervention on Depressive Symptoms

Comparision of Spirituality Integrated Psychotherapy (SIPT), Cognitive-Behavioral Therapy (CBT) and Medication Intervention on reduction of Depressive Symptoms and Dysfunctional Attitudes in Patients with Dysthymic Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201108157339N1
Enrollment
62
Registered
2012-08-19
Start date
2006-09-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysthimic Disorder. Dysthymia

Interventions

Intervention 1: Group1:Spritually Integrated psychotherapy include cognitive, behavioral,emotional,spritual strategies based on religious sources. SIPT were presented in 8 sessions, each week, a 45
Treatment - Drugs
Group1:Spritually Integrated psychotherapy include cognitive, behavioral,emotional,spritual strategies based on religious sources. SIPT were presented in 8 sessions, each week, a 45-minute individu
Group2: cognitive behavior therapy with using a standard protocol in the form of eight 45-minute sessions, one session per week,Individually
Group3:routin antidepressant medication therapy, Citalopram was initiated at 20 mg/day, and increased to a maximum of 60 mg/day
Control Group: no any intervention ( waiting list )

Sponsors

Isfahan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included dysthymic disorder diagnosis according to DSM-IV-TR; age between 20 and 65 years old; Persian language; Exclusion comorbidity with severe physical diseases; serious neurology; mental retardation; psychosis disorders or symptoms; bipolar disorder; depression disorders resulting from drug and alcohol abuse and other psychiatric disorders with depression as their secondary symptoms; reluctance of the patient to continue the therapy; serious suicide ideation and risk of suicide which require emergency intervention.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of depressive symptoms (self-report). Timepoint: before intervention,after 4week,after intervention,3month afterintervention(follow out). Method of measurement: Beck Depression Inventory(BDI-II).;Severity of anxiety symptoms(clinician rating). Timepoint: before intervention,after 4week,after intervention,3month afterintervention(follow out). Method of measurement: Hamilton Rating Scale for Depression(HRSD).;Dysfunctional attitude. Timepoint: before intervention,after 4week,after intervention,3month afterintervention(follow out). Method of measurement: Dysfunctional Attitude Scale (DAS-26).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmrollah Ebrahimi

Psychosomatic Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

a_ebrahimi@med.mui.ac.ir+98 31 1222 2135

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026